| Pharmaceutical active ingredients: |
| Sulpiride |
| Available forms, composition and doses of Dixibon: |
| N / A |
| Dixibon medical category: |
| Human:Antacids, antireflux agents and antiulcerants |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N05AL01 - SulpirideN05AL07 - Levosulpiride |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Dixer-S | Diclofenac Potassium; Serrapeptase | Biophar Lifesciences |
| Dixfree-SP | Acetaminophen; Diclofenac Potassium; Serrapeptase | Zenetica Pharma |
| Dixi | Amoxicillin; Dicloxacillin | Arvincare Healthcare |
| Dixi-35 | Cyproterone Acetate; Ethinyl Estradiol | Recalcine Laboratorios |
| Dixiben | Nalidixic Acid | Unidentified Pharmaceutical Company |
| Dixidrasi | Hydrochlorothiazide | Unidentified Pharmaceutical Company |
| Dixidrol | Glucose; Potassium Chloride; Sodium Chloride; Sodium Citrate | P. L. Rivero Laboratorios |
| Dixifes | Deflazacort | Aamorb Pharmaceuticals |
| Dixiflen | Cellulase; Dimethicone; Ox Bile; Pancreatin | Profesional Medica Farcoral |
| Dixin | Digoxin | Samarth Pharma |